lifestyle.pluralist.com

Author: Alligator Bioscience

Notice of Annual General Meeting in Alligator Bioscience AB

March 30, 2026
The Nomination Committee’s Proposals Regarding the Board of Directors for the Annual General Meeting in Alligator Bioscience AB (publ)

March 27, 2026
Alligator Bioscience Publishes Annual Report for 2025

March 26, 2026
New data from Investigator‑Initiated Study Evaluating Alligator Bioscience’s Mitazalimab to be Presented at AACR Annual Meeting 2026

March 18, 2026
Alligator Bioscience Strengthens Intellectual Property Protection for Bispecific Antibody Platform

March 10, 2026
Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22

March 2, 2026
Exercise Price Determined for the Exercise of Warrants Series TO 14 in Alligator Bioscience AB

February 27, 2026
Alligator Bioscience AB Reports Full Year Financial Results for 2025 and for Q4 2025 and Provides a Business Update

February 12, 2026
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026

February 11, 2026
Change in Number of Shares and Votes in Alligator Bioscience AB

January 30, 2026